Stay updated on Obeldesivir Study in High-risk COVID-19: Clinical Trial

Sign up to get notified when there's something new on the Obeldesivir Study in High-risk COVID-19: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Obeldesivir Study in High-risk COVID-19: Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Taoyuan, Taiwan, 320 has been updated to Taoyuan City, Taiwan, 320. The locality name was updated while preserving the postal code, reflecting an official naming update in the study's location list.
    Difference
    0.0%
    Check dated 2026-05-08T12:27:33.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The page’s footer revision identifier was updated from **v3.5.2** to **v3.5.3**, indicating a ClinicalTrials.gov page version refresh without changing the study details shown.
    Difference
    0.0%
    Check dated 2026-04-24T06:24:46.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2 on the page.
    Difference
    0.0%
    Check dated 2026-04-17T02:42:24.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0, indicating a system/template update across the page.
    Difference
    0.0%
    Check dated 2026-03-19T05:24:10.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    Page revision note updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T23:46:47.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    A new citation for SARS-CoV-2 resistance analyses from the Phase 3 BIRCH study was added, and the earlier version of that citation was removed.
    Difference
    0.0%
    Check dated 2026-02-25T18:59:46.000Z thumbnail image

Stay in the know with updates to Obeldesivir Study in High-risk COVID-19: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Obeldesivir Study in High-risk COVID-19: Clinical Trial page.